Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yun Kyung Cho, Jae‐Hyoung Cho, Sang‐Mo Hong, Jung Hwan Park, Byung‐Wan Lee, Jee Hee Yoo, Jae Hyeon Kim, Sung Wan Chun, You‐Cheol Hwang, Kee‐Ho Song, Woo Je Lee
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet